[ad_1]
A recently released University of Michigan Health (U-M Health) impact report outlines the progress and work made possible by Birmingham-based Dynami Foundation’s initiatives, which focus on transforming the future of invasive lobular breast cancer (ILC) through the funding of research.
The foundation is a nonprofit organization whose mission is to raise funds for the purpose of contributing to cancer research and treatment. In addition to fundraising for cancer research and treatment, it provides financial assistance to families affected by cancer.
“The Dynami Foundation is impactful through so many critical initiatives, including support for scientists studying novel approaches to treat cancer, support for physicians fighting this disease, and support for the compassionate care of patients dealing with a cancer diagnosis,” says Dr. Jacqueline S. Jeruss, associate vice president for research at the University of Michigan in Ann Arbor.
From new research on circulating cells to a dual-institution effort to combat cancer, Dynami and U-M Health have partnered to drive progress. Here are just a few of the initiatives underway:
- Never-before-seen opportunity to monitor ILC recurrence and propel the detection of cell transformation through Drs. Jacqueline Jeruss and Lonnie Shea’s work.
- Biomarker research led by Dr. Celina Kleer which includes investigating the significance of recent findings presented at the annual meeting of the United States and Canadian Academy of Pathology.
- Internationally recognized breast oncologist, Dr. Daniel Hayes’s research on circulating tumor cells to combat cancer cells’ tendency to mutate and evolve in ways that make them resistant to treatments.
- Faster results and more precision through a dual-institutional approach to streamline research efforts and bring together the nation’s top thinkers between University of Colorado and U-M Health.
- A patient-centered decision-making process by understanding goals of lobular breast cancer patients for an elevated, personalized breast reconstruction experience led by Dr. Paige Myers.
- Dr. Molly Moravek’s research on women who either underwent fertility preservation prior to treatment or who are in remission from breast cancer and using IVF to have children.
- Research into breast cancer risk among Black women who have a prior history of benign breast disease in conjunction with Dr. Versha Pleasant.
The research highlighted in U-M Health’s latest Impact Report builds upon the strategic partnership between Dynami, U-M Health, the University of Pittsburgh Medical Cancer (UPMC), and U-M Health on research projects.
“Research is what makes progress possible, even one powerful idea pursued to the fullest,” says Flora Migyanka, founder of Dynami. “It’s a beacon of hope that guides us toward a world where cancer is not a life sentence. It is the cornerstone upon which the future of cancer is built. Dynami has funded over 12 research projects and will continue to fight for advancement for lobular breast cancer just like the incredible work and impact that we’ve made here.”
To read more about the partnership and how Dynami’s donations are directly driving results and further research at University of Michigan, to read the full impact report, visit here.
To join the Dynami Foundation in raising additional funds to drive further research into ILC, please attend the 8th Annual Uncork for a Cure on November 4th at the M1 Concourse. For more information, tickets, and sponsorship, visit the DynamiFoundation.org.
[ad_2]
Source link
